• Drugs via Skin Patches: 1) Covid-19 Vaccines Patch? 2) Smart Insulin Pa

    From _@21:1/5 to All on Sun Oct 31 16:18:05 2021
    ---
    October 30 2021

    Needle-Free Covid Vaccine Patches
    Coming Soon, Say Researchers https://www.ndtv.com/world-news/needle-free-covid-vaccine-patches-coming-soon-say-researchers-2593042
    ---

    Apart from being painless, Covid vaccine
    skin patches could assist with distribution
    efforts, because they don't have cold-chain
    requirements -- and might even heighten
    vaccine efficacy.

    ... Human trials are planned from April 2022.

    ... Vaxess has just opened a factory near Bos-
    ton, with funding from the US National Insti-
    tutes for Health. They aim to produce enough
    patches to vaccinate 2,000 to 3,000 people in
    clinical trials, which are to be launched next
    summer 2022.

    ... "This is the future, in my opinion, it is inevit-
    able. ... "I think you're going to see over the next
    10 years, this (will) pretty dramatically reshape
    the way that we get vaccines around the world."

    - - - end excerpts - - -

    "Soon" is a relative term but with the current Co-
    vid-19 pandemic threatening the world,
  • From _@21:1/5 to All on Wed Nov 3 08:13:11 2021
    Follow-up:

    This article covers several glucose sensing
    products, among them a glucose-sensing
    patch similar to the patches discussed in
    the original article to sense glucose levels
    in what they call a wearable non-invasive
    glucose sensing patch (November 2 2021): https://www.fiercebiotech.com/medtech/biolinq-amasses-100m-for-its-painless-glucose-sensor-patch

    On Sunday, October 31, 2021 at 6:18:06 PM UTC-5, _ wrote:

    ---
    October 30 2021

    Needle-Free Covid Vaccine Patches
    Coming Soon, Say Researchers https://www.ndtv.com/world-news/needle-free-covid-vaccine-patches-coming-soon-say-researchers-2593042
    ---

    Apart from being painless, Covid vaccine
    skin patches could assist with distribution
    efforts, because they don't have cold-chain
    requirements -- and might even heighten
    vaccine efficacy.

    ... Human trials are planned from April 2022.

    ... Vaxess has just opened a factory near Bos-
    ton, with funding from the US National Insti-
    tutes for Health. They aim to produce enough
    patches to vaccinate 2,000 to 3,000 people in
    clinical trials, which are to be launched next
    summer 2022.

    ... "This is the future, in my opinion, it is inevit-
    able. ... "I think you're going to see over the next
    10 years, this (will) pretty dramatically reshape
    the way that we get vaccines around the world."

    - - - end excerpts - - -

    "Soon" is a relative term but with the current Co-
    vid-19 pandemic threatening the world, some-
    thing like this can't come soon enough, and just
    my take on it, I don't perceive "soon" is applicable
    pertaining to clinical trials starting in April & ...

    ... Summer 2022 & whatever the article is refer-
    encing when it mentions "the next 10 years".

    ~~~ ~~~ ~~~

    Skin patches have been undergoing research &
    development for insulin delivery for quite some
    time now (link to a 2018 article about several
    projects involving various smart insulin delivery
    methods including via insulin patches):

    - - -
    December 19, 2018

    Smart Insulin: An Overview of All Projects https://mailchi.mp/thejdca/how-smart-is-smart-insulin-an-overview-of-all-projects-430289?e=9e2383f2eb
    - - -

    Note - The following article mistakenly conveys
    that everyone with any of the 7 DHGCs (see below)
    will rely on the technology, as they use the old out-
    dated anachronistic misleading confusing diabetes
    word without clarifier -9- times in the article.

    Everyone? That's probably not true, but it's obvious
    that all with Islit will rely on it, unclear the extent to
    which those with non-Islit DHGCs not using exogen-
    ous insulin currently would be treated via this new
    device (assuming it's approved after human clinical
    trials at some point in the future).

    - - -
    February 14 2020

    Smart insulin-delivery patch could revolutionize
    management of glucose levels for exogenous
    insulin-requiring Disparate High Glucose Condi-
    tions (DHGCs) one day (all with Islit, Insulinitis,
    near-total to total loss of endogenous insulin, ...

    ... require multiple doses of exogenous insulin
    daily, but about 95% with non-Islit DHGCs don't
    use exogenous insulin, instead relying on oral
    &/or injected non-insulin medication(s) &/or
    exercise &/or diet to deal with problematic con-
    tinued endogenous insulin availability, oft-times ...

    ... hampered by insulin resistance, but each of
    the 7 DHGCs has unique causality / treatment /
    risk profiles. https://www.plasticstoday.com/medical/smart-insulin-delivery-patch-could-revolutionize-diabetes-management-one-day
    - - -

    Smart Insulin Patch Photo - About the size of a
    quarter, the adhesive patch monitors glucose lev-
    els & automatically delivers insulin, in the dosages
    required, via micro-needles made from a glucose-
    sensing polymer. .https://www.plasticstoday.com/sites/plasticstoday.com/files/styles/article_featured_standard/public/smart-insulin-patch-400.jpg?itok=M8mB3yOB

    ... Researchers at the University of California Los
    Angeles (UCLA), the University of North Carolina
    School of Medicine & Massachusetts Institute of
    Technology are developing the technology, which
    they describe in a recent issue of Nature Biomed-
    ical Engineering:

    - - -
    Published February 3 2020

    Glucose-responsive insulin patch for the
    regulation of blood glucose in mice and
    minipigs
    https://www.nature.com/articles/s41551-019-0508-y
    - - -

    Having successfully tested the technology on animals,
    the research team, led by Zhen Gu, PhD, professor of
    bioengineering at the UCLA Samueli School of Engin-
    eering, has applied for FDA approval of clinical trials
    in humans.

    ... The researchers are applying for FDA approval for
    human clinical trials, which they anticipate could start
    within a few years.

    - - -
    Last Update Posted : October 22, 2021

    Efficacy and Safety of Recombinant
    Human Insulin Patch ZJSRM2021
    ClinicalTrials.gov Identifier: NCT05089942 https://clinicaltrials.gov/ct2/show/NCT05089942
    - - -

    [clarifying inserts, not part of original article,
    included in brackets]

    The aim of this study is to investigate the efficacy,
    safety, and tolerability of the recombinant human
    insulin patch ZJSRM2021 in healthy [well, in the
    view of many, having any of the 7 DHGCs makes
    one by definition unhealthy, but I suppose it's all ...

    ... a matter of how one decides one is healthy or
    not] subjects, type 1 diabetes mellitus [Islit] and
    type 2 diabetes mellitus [Cellosis] patients.

    ...

    Estimated Study Start Date : December 2021
    Estimated Primary Completion Date : December 2021
    Estimated Study Completion Date : December 2022

    ...

    [see article for further details]

    - - - end of excerpts - - -

    ~!~ ~!~ ~!~ ~!~ ~!~ ~!~ ~!~ ~!~ ~!~ ~!~ ~!~

    The old confusing way which all-too-often
    involves folks using the diabetes / diabetic
    words without a clarifier:

    diabetes / diabetic without a clarifier,
    diabetes / diabetic guessing required https://prohuman.net/pix2/diabetesdiabeticguessinggame.jpg

    - - -

    Pro-Humanist FREELOVER, promoting
    since May 17 2010 putting an end to all
    outdated confusing misleading diabetes/
    diabetic ways of referring to each and all
    of Disparate High Glucose Conditions
    (DHGCs) and one mostly non-glucose ...

    ... anomaly and one low glucose anomaly
    which uses an outdated confusing reactive
    hypoglycemia term, ... https://prohuman.net/pix2/diabetesdiabeticconfusion.jpg https://prohuman.net/pix2/diabetesdiabeticendingthemisunderstanding.jpg

    ... replacing all of that with new superior
    clarifying medical terms which hopefully
    will end diabetes/diabetic/reactive hypo-
    glycemia confusion & misleading, putting
    an end to the use of those terms, totally: https://prohuman.net/pix2/diabetesbubblediabetesbubblebursttitle.jpg https://prohuman.net/pix2/diabetesreactivehypoglycemiaoldnamesnewnames.jpg https://prohuman.net/pix2/oldnamesnewimprovednames.jpg

    o There are 15 specific types of rapid onset
    Insulinitis (Islit). I've had Insulitis Islit (the pre-
    dominate type) since March 1961, age 5. https://prohuman.net/pix2/new_superior_clarifying_name_is_INSULINITIS.jpg

    o There is 1 slow onset type of Islit, Latent
    Autoimmune Islit.

    o There are 21 specific types of the most
    widespread DHGC which is present in up to
    95% of those with any DHGC, Cellosis, new
    superior clarifying name for type 2 diabetes,
    its precondition is called PreCellosis.

    The only preventable/reversible DHGC is
    Preventable Cellosis, new clarifying specific
    type of the preventable type 2 diabetes, esti-
    mated to be the type that at least 85% of
    Americans with Cellosis have.

    Risk for Preventable Cellosis, Hypertension,
    & Cardiovascular Disease increases as one's
    weight increases but BMI risk increases at
    lower BMI levels in non-white individuals: https://prohuman.net/pix2/BMI-WaistCircumference-Cellosis&Hypertension&CardiovascularDisease-Risk.jpg
    https://medicalxpress.com/news/2021-05-bmi-offs-obesity-diabetes-non-white.html

    o There is 1 specific type of DHGC that
    happens in < 10% of pregnancies called
    Gestational Cellosis.

    o There are 11 specific types of diminished
    insulin production, monogenic conditions
    called Diminosis.

    o There are 12 specific type of diminished
    insulin production that occurs up to 6 months
    after birth, monogenic conditions called Neo-
    natal Diminosis.

    o There are 25 specific types of continued but
    problematic DHGCs called Ohiglucons (Other
    High Glucose Conditions).

    o There are 6 specific types of a mostly non-
    glucose anomaly called Insipidus.

    o There are 21 specific types of Hypoglycemia
    Uncaused by Treatments for High Glucose (Hut).

    Details on all of those DHGCs / a mostly non-
    glucose anomaly / a low glucose anomaly:

    Diabetes Bubble / Diabetes Bubble Burst
    Wonderful! https://prohuman.net/diabetesbubblediabetesbubbleburst.htm

    C.ure I.nsulinitis A.ssociation
    Ideal! https://prohuman.net/cureinsulinitisassociation.htm

    Glucose Anomalies Research regarding
    Potential Cures / Improvements in Treatments
    Hopefully! https://prohuman.net/glucoseanomaliesresearch.htm

    - - -

    Those who favor new terms, the following
    is inspirational:

    I Do Not Like Diabetes Here or There,
    I Do Not Like Diabetes Anywhere https://smile.amazon.com/Not-Like-Diabetes-Anywhere-shirt/dp/B01N25FMMI/ref=pd_d0_recs_v2_cwb_193_3?_encoding=UTF8&refRID=WJHV2S8X0YG21Z9WVQD5&th=1

    See No
    Speak No
    Hear No
    DIABETES
    Faith Will Make It So https://smile.amazon.com/CafePress-Speak-Diabetes-Unique-Coffee/dp/B014JS6QDI/ref=sr_1_2_sspa?s=home-garden&ie=UTF8&qid=1513534468&sr=1-2-spons&keywords=diabetes+cup&psc=1

    Syllables - Comparison of old
    diabetes terms / new terms https://prohuman.net/diabetesoldtermsnewtermssyllables.htm

    Stop Diabetes/Diabetic Confusion
    with New Superior Clarifying Terms https://www.change.org/stopdiabetesdiabeticconfusionwithNewSuperiorClarifyingTerms

    ~!~ ~!~ ~!~ ~!~ ~!~ ~!~ ~!~ ~!~ ~!~ ~!~ ~!~

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)